The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Carl L. McMillian
Advertisement
Carl L. McMillian is vice-president, Toxicology, Drug Disposition, PK/PD, Eli Lilly and Company.
Articles by Carl L. McMillian
Advertisement
Latest Updated Articles
Advertisement
Advertisement